LTOT i Danmark 1994-2000
Thomas Ringbæk, Hvidovre Hospital
Peter Lange, Hvidovre Hospital
Fokus områder
Diagnoser
Prævalensen
Incidensen
Patient-karakteristika: alder, køn
Behandlingskvaliteten: >15 timer dagligt
tobaksrygning
ambulant kontrol
Iltudstyr
Overlevelse
Dansk Iltregister siden
november 1994
Iltleverandører vedr. 98-99% alle patienter
Spørgeskema vedr. nystartede i 1995
Journaler vedr. diagnose, medicinering,
blodgasser, htc., EKG/EKKO og tobak
Centrale registre: Vital status, kontakter med
sundhedsvæsenet
Prævalens af LTOT 1994-2000
0
10
20
30
40
50
60
70
80
31.10.94 31.12.95 31.12.96 31.12.97 31.12.98 31.12.99 31.12.00
per100.000
Missing
Others
Cancer
COPD
Incidens af LTOT 1995-2000
0
10
20
30
40
50
60
70
1995 1996 1997 1998 1999 2000
per100.000
Missing
Others
Cancer
COPD
Ændringen i iltordination og patient-
karakteristika fra 1995 til 2000
0
10
20
30
40
50
60
70
80
90
1995 1996 1997 1998 1999 2000
%
Initiated after
admission
Outpatient clinic 1-6
months after start
Started by GP
0
10
20
30
40
50
60
70
80
90
1995 1996 1997 1998 1999 2000
%
15-24 hrs/day
Age>70 yrs
Mobile oxygen
0
10
20
30
40
50
60
70
01.11.9431.12.9531.12.9631.12.9731.12.9831.12.9931.12.00
%
Females
Age>70 yrs
Flow >1.5 L/minute
0
10
20
30
40
50
60
70
80
90
100
01.11.9431.12.9531.12.9631.12.9731.12.9831.12.9931.12.00
%
Oxygen
concentrator or
liquid oxygen
15-24 hrs/day
Mobile oxygen
Smoking status of COPD patients, residing in the central part of
Copenhagen, and on LTOT in 1995 and 2000, respectively.
1995
n=240
2000
n=279
P-level for
difference
Asked about smoking
Admitted smoking (% of
asked patients)
180(75.0%)
 
34(20.4%)1
216(77.4%)
 
32(15.5%)2
0.52
 
0.23
Measured CO
Abnormal value
(% of checked patients)
136(56.7%)
 
21(15.4%)
141(50.5%)
 
19(15.8%)
0.16
 
0.64
Asked about smoking or
measured CO-level
Indication of smoking
(% of asked or checked)
187(77.1%)
 
47(25.1%)
222(79.6%)
 
47(21.2%)
0.65
 
0.34
1) 13 cases of “don’t know” 2) 10 cases of “don’t know”
Survival rates of new COPD patients on LTOT from
Denmark compared to patients from other countries
0
10
20
30
40
50
60
70
80
90
100
0 3 6 9 12 15 18 21 24 27 30 33 36 39
months
cumulativesurvivalproportion(%).
Denmark (n=5659)
Sweden (n=403)
Belgium (n=270)
France (n=252)
Australia (n=505)
Survival of COPD patients who
started LTOT in 1995 versus 1999
0,00 0,50 1,00 1,50 2,00 2,50 3,00 3,50 4,00 4,50 5,00 5,50 6,00
Years
0,0
0,2
0,4
0,6
0,8
1,0
CumSurvival
Year of start
1995
1999
Median
1.07 vs
1.40 yrs;
p=0.032
Konklusion
↑ Andel af patienter med cancer
↑ Incidens og prævalens af KOL -
nået plateau omk. 25 og 40 per 100.000
↑ Mobil-ilt, ↑ starter efter indl. og ↑ alder
↑ ”15-24 timer/dag”
Kun ca. 50% følges i medicinsk amb.
Mindst 20-25% ryger
Dårligere overlevelse end udlandet pga.
meget højere 6-måneders mortalitet
↑ Overlevelse

Ltot i danmark 1994 2000

  • 1.
    LTOT i Danmark1994-2000 Thomas Ringbæk, Hvidovre Hospital Peter Lange, Hvidovre Hospital
  • 2.
    Fokus områder Diagnoser Prævalensen Incidensen Patient-karakteristika: alder,køn Behandlingskvaliteten: >15 timer dagligt tobaksrygning ambulant kontrol Iltudstyr Overlevelse
  • 3.
    Dansk Iltregister siden november1994 Iltleverandører vedr. 98-99% alle patienter Spørgeskema vedr. nystartede i 1995 Journaler vedr. diagnose, medicinering, blodgasser, htc., EKG/EKKO og tobak Centrale registre: Vital status, kontakter med sundhedsvæsenet
  • 4.
    Prævalens af LTOT1994-2000 0 10 20 30 40 50 60 70 80 31.10.94 31.12.95 31.12.96 31.12.97 31.12.98 31.12.99 31.12.00 per100.000 Missing Others Cancer COPD
  • 5.
    Incidens af LTOT1995-2000 0 10 20 30 40 50 60 70 1995 1996 1997 1998 1999 2000 per100.000 Missing Others Cancer COPD
  • 6.
    Ændringen i iltordinationog patient- karakteristika fra 1995 til 2000 0 10 20 30 40 50 60 70 80 90 1995 1996 1997 1998 1999 2000 % Initiated after admission Outpatient clinic 1-6 months after start Started by GP 0 10 20 30 40 50 60 70 80 90 1995 1996 1997 1998 1999 2000 % 15-24 hrs/day Age>70 yrs Mobile oxygen 0 10 20 30 40 50 60 70 01.11.9431.12.9531.12.9631.12.9731.12.9831.12.9931.12.00 % Females Age>70 yrs Flow >1.5 L/minute 0 10 20 30 40 50 60 70 80 90 100 01.11.9431.12.9531.12.9631.12.9731.12.9831.12.9931.12.00 % Oxygen concentrator or liquid oxygen 15-24 hrs/day Mobile oxygen
  • 7.
    Smoking status ofCOPD patients, residing in the central part of Copenhagen, and on LTOT in 1995 and 2000, respectively. 1995 n=240 2000 n=279 P-level for difference Asked about smoking Admitted smoking (% of asked patients) 180(75.0%)   34(20.4%)1 216(77.4%)   32(15.5%)2 0.52   0.23 Measured CO Abnormal value (% of checked patients) 136(56.7%)   21(15.4%) 141(50.5%)   19(15.8%) 0.16   0.64 Asked about smoking or measured CO-level Indication of smoking (% of asked or checked) 187(77.1%)   47(25.1%) 222(79.6%)   47(21.2%) 0.65   0.34 1) 13 cases of “don’t know” 2) 10 cases of “don’t know”
  • 8.
    Survival rates ofnew COPD patients on LTOT from Denmark compared to patients from other countries 0 10 20 30 40 50 60 70 80 90 100 0 3 6 9 12 15 18 21 24 27 30 33 36 39 months cumulativesurvivalproportion(%). Denmark (n=5659) Sweden (n=403) Belgium (n=270) France (n=252) Australia (n=505)
  • 9.
    Survival of COPDpatients who started LTOT in 1995 versus 1999 0,00 0,50 1,00 1,50 2,00 2,50 3,00 3,50 4,00 4,50 5,00 5,50 6,00 Years 0,0 0,2 0,4 0,6 0,8 1,0 CumSurvival Year of start 1995 1999 Median 1.07 vs 1.40 yrs; p=0.032
  • 10.
    Konklusion ↑ Andel afpatienter med cancer ↑ Incidens og prævalens af KOL - nået plateau omk. 25 og 40 per 100.000 ↑ Mobil-ilt, ↑ starter efter indl. og ↑ alder ↑ ”15-24 timer/dag” Kun ca. 50% følges i medicinsk amb. Mindst 20-25% ryger Dårligere overlevelse end udlandet pga. meget højere 6-måneders mortalitet ↑ Overlevelse